$DMTKQ
DermTech Inc

2021 Q3 Form 10-Q Financial Statement

#000156459021055781 Filed on November 09, 2021

View on sec.gov

Income Statement

Concept 2021 Q3 2020 Q3 2020 Q2
Revenue $3.030M $1.362M $844.0K
YoY Change 122.47% 141.06% 37.46%
Cost Of Revenue $2.898M $1.608M $1.445M
YoY Change 80.22% 106.42%
Gross Profit $132.0K -$246.0K -$601.0K
YoY Change -153.66% 14.95% 734.72%
Gross Profit Margin 4.36% -18.06% -71.21%
Selling, General & Admin $16.03M $7.533M $7.962M
YoY Change 112.73% 45.2% 190.8%
% of Gross Profit 12140.15%
Research & Development $4.426M $1.618M $864.0K
YoY Change 173.55% 113.74%
% of Gross Profit 3353.03%
Depreciation & Amortization $300.0K $200.0K $100.0K
YoY Change 50.0% 900.0% 0.0%
% of Gross Profit 227.27%
Operating Expenses $20.45M $9.151M $8.826M
YoY Change 123.48% 53.93% 171.07%
Operating Profit -$20.32M -$9.397M -$9.427M
YoY Change 116.23% 52.57% 183.26%
Interest Expense $38.00K $9.000K $10.00K
YoY Change 322.22% -102.47% -103.09%
% of Operating Profit
Other Income/Expense, Net $207.0K $116.0K -$170.0K
YoY Change 78.45% -73.21% 325.0%
Pretax Income -$20.11M -$9.390M -$9.420M
YoY Change 114.19% 63.87% 6628.57%
Income Tax
% Of Pretax Income
Net Earnings -$20.11M -$9.281M -$9.597M
YoY Change 116.7% 62.09% 159.94%
Net Earnings / Revenue -663.76% -681.42% -1137.09%
Basic Earnings Per Share -$0.68
Diluted Earnings Per Share -$678.5K -$496.0K -$583.3K
COMMON SHARES
Basic Shares Outstanding 29.64M shares
Diluted Shares Outstanding 29.64M shares

Balance Sheet

Concept 2021 Q3 2020 Q3 2020 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $249.4M $51.50M $61.10M
YoY Change 384.36% 140.65%
Cash & Equivalents $204.1M $14.63M $61.10M
Short-Term Investments $45.38M $36.90M
Other Short-Term Assets $178.0K $1.900M $50.00K
YoY Change -90.63% 7816.67%
Inventory $424.0K $115.0K $100.0K
Prepaid Expenses
Receivables $2.819M $1.007M $700.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $254.3M $54.53M $62.50M
YoY Change 366.24% 130.16% 102305.3%
LONG-TERM ASSETS
Property, Plant & Equipment $4.295M $2.324M $2.100M
YoY Change 84.81% 1006.67%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $167.0K $167.0K $200.0K
YoY Change 0.0% 98.81%
Total Long-Term Assets $15.65M $2.491M $2.200M
YoY Change 528.18% 747.28% -82.3%
TOTAL ASSETS
Total Short-Term Assets $254.3M $54.53M $62.50M
Total Long-Term Assets $15.65M $2.491M $2.200M
Total Assets $269.9M $57.03M $64.70M
YoY Change 373.31% 137.72% 417.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.504M $819.0K $800.0K
YoY Change 205.74% -18.43% -66.67%
Accrued Expenses $1.950M $484.0K $2.600M
YoY Change 302.89% 183.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $145.0K
YoY Change
Total Short-Term Liabilities $10.80M $4.098M $5.800M
YoY Change 163.52% -19.65% 134.9%
LONG-TERM LIABILITIES
Long-Term Debt $216.0K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $6.969M $700.0K
YoY Change 895.57%
Total Long-Term Liabilities $7.185M $700.0K $0.00
YoY Change 926.43%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.80M $4.098M $5.800M
Total Long-Term Liabilities $7.185M $700.0K $0.00
Total Liabilities $17.98M $5.374M $6.466M
YoY Change 234.65% 5.37% -4.65%
SHAREHOLDERS EQUITY
Retained Earnings -$180.3M -$117.3M -$108.0M
YoY Change 53.68% 36.43% -6611.63%
Common Stock $432.2M $169.0M $166.3M
YoY Change 155.8% 4877.06%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $251.9M $51.65M $58.22M
YoY Change
Total Liabilities & Shareholders Equity $269.9M $57.03M $64.69M
YoY Change 373.31% 137.72% 417.81%

Cashflow Statement

Concept 2021 Q3 2020 Q3 2020 Q2
OPERATING ACTIVITIES
Net Income -$20.11M -$9.281M -$9.597M
YoY Change 116.7% 62.09% 159.94%
Depreciation, Depletion And Amortization $300.0K $200.0K $100.0K
YoY Change 50.0% 900.0% 0.0%
Cash From Operating Activities -$15.90M -$8.160M -$6.380M
YoY Change 94.84% -30.14% 24720.07%
INVESTING ACTIVITIES
Capital Expenditures -$720.0K -$380.0K -$1.020M
YoY Change 89.47% 660.0%
Acquisitions
YoY Change
Other Investing Activities -$6.876M -$36.91M
YoY Change -81.37%
Cash From Investing Activities -$7.596M -$37.28M -$1.020M
YoY Change -79.62% 74460.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 971.0K -1.040M 590.0K
YoY Change -193.37% -103.66% 5519.05%
NET CHANGE
Cash From Operating Activities -15.90M -8.160M -6.380M
Cash From Investing Activities -7.596M -37.28M -1.020M
Cash From Financing Activities 971.0K -1.040M 590.0K
Net Change In Cash -22.52M -46.48M -6.810M
YoY Change -51.54% -378.16% 44687.9%
FREE CASH FLOW
Cash From Operating Activities -$15.90M -$8.160M -$6.380M
Capital Expenditures -$720.0K -$380.0K -$1.020M
Free Cash Flow -$15.18M -$7.780M -$5.360M
YoY Change 95.1% -33.1%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3030000
CY2020Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
CY2019Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.5
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y3M29D
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M1D
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1379000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
145000
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6561000
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
408000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
639000
CY2021Q3 us-gaap Liabilities
Liabilities
17984000
CY2020Q4 us-gaap Liabilities
Liabilities
7940000
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29717198
CY2021Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29717198
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20740413
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
20740413
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128029000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
61840000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
69780000
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000
CY2021Q3 us-gaap Assets
Assets
269905000
CY2021Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
2504000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3464000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1950000
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1357000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3024000
CY2020Q4 us-gaap Assets
Assets
69780000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
763000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
905000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1573000
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8162000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
167000
CY2020Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1650000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
216000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
226000
CY2021Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
432237000
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-8000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5425000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
189868000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2075000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
109000
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
10799000
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
3000
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-180311000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
251921000
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
269905000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10980000
us-gaap Cost Of Revenue
CostOfRevenue
4256000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
10973000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3380000
us-gaap Operating Expenses
OperatingExpenses
25333000
us-gaap Operating Income Loss
OperatingIncomeLoss
-25825000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
19000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
116000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1243000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9281000
us-gaap Net Income Loss
NetIncomeLoss
-52282000
us-gaap Net Income Loss
NetIncomeLoss
-25775000
CY2020Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
18928418
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28599375
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
16069989
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.83
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.61
CY2020Q4 us-gaap Inventory Net
InventoryNet
104000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
66882000
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
39529000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1480000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1521000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2731000
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2939000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
17672000
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
20451000
us-gaap Gross Profit
GrossProfit
1149000
us-gaap Gross Profit
GrossProfit
-492000
CY2021Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9826000
CY2020Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
4594000
CY2021Q3 us-gaap Gross Profit
GrossProfit
132000
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4426000
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6199000
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-20319000
CY2021Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
38000
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-169000
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
207000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20112000
CY2021Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
29639802
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.68
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20112000
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-20122000
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1362000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
3764000
CY2021Q3 us-gaap Cost Of Revenue
CostOfRevenue
2898000
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
1608000
us-gaap Cost Of Revenue
CostOfRevenue
7524000
CY2020Q3 us-gaap Gross Profit
GrossProfit
-246000
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24245000
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1618000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10271000
CY2020Q3 us-gaap Operating Expenses
OperatingExpenses
9151000
us-gaap Operating Expenses
OperatingExpenses
52188000
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-9397000
us-gaap Operating Income Loss
OperatingIncomeLoss
-51039000
CY2020Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
9000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
107000
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-107000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1350000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9281000
us-gaap Net Income Loss
NetIncomeLoss
-52282000
us-gaap Net Income Loss
NetIncomeLoss
-25775000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-7000
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9281000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-52289000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-25775000
CY2020Q1 dmtk Adjustments To Additional Paid In Capital Issuance Of Series B1 Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesB1ConvertiblePreferredStock
30971000
CY2020Q1 dmtk Adjustments To Additional Paid In Capital Issuance Of Series B2 Convertible Preferred Stock
AdjustmentsToAdditionalPaidInCapitalIssuanceOfSeriesB2ConvertiblePreferredStock
5071000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
253000
CY2020Q1 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
11000
CY2020Q1 dmtk Adjustments To Additional Paid In Capital Issuance Cost Related To Registration
AdjustmentsToAdditionalPaidInCapitalIssuanceCostRelatedToRegistration
-77000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1022000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-6897000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
66106000
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1000
CY2020Q2 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
123000
CY2020Q2 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
471000
CY2020Q2 dmtk Adjustments To Additional Paid In Capital Issuance Cost Related To Registration
AdjustmentsToAdditionalPaidInCapitalIssuanceCostRelatedToRegistration
-5000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1125000
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
-9597000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
58224000
CY2020Q3 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
24000
CY2020Q3 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
300000
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1373000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9281000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
51651000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
61840000
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
134582000
CY2021Q1 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
408000
CY2021Q1 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
72081000
CY2021Q1 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
392000
CY2021Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
9000
CY2019Q4 dmtk Warrant Liability Non Current
WarrantLiabilityNonCurrent
628000
CY2019Q4 us-gaap Liabilities
Liabilities
6350000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103412000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11861000
CY2020Q3 dmtk Warrant Liability Non Current
WarrantLiabilityNonCurrent
597000
CY2020Q3 us-gaap Liabilities
Liabilities
5374000
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-117327000
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
51651000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11861000
CY2021Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-6000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3538000
CY2021Q2 dmtk Reclassification Of Warrant Liability Due To Private Spac Warrants Not Held By Original Holder
ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
23000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-17102000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2172000
CY2021Q1 dmtk Reclassification Of Warrant Liability Due To Private Spac Warrants Not Held By Original Holder
ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
411000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-15068000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
256827000
CY2021Q2 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
188000
CY2021Q2 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
5000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
267309000
CY2021Q3 dmtk Stock Issued During Period Value Stock Options Exercised And Rsu Release
StockIssuedDuringPeriodValueStockOptionsExercisedAndRSURelease
81000
CY2021Q3 dmtk Stock Issued During Period Value Common Stock Warrants Exercised
StockIssuedDuringPeriodValueCommonStockWarrantsExercised
343000
CY2021Q3 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
574000
CY2021Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-10000
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3736000
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-20112000
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
251921000
us-gaap Profit Loss
ProfitLoss
-52282000
us-gaap Profit Loss
ProfitLoss
-25775000
us-gaap Depreciation
Depreciation
654000
us-gaap Depreciation
Depreciation
306000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1350000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31000
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
909000
us-gaap Share Based Compensation
ShareBasedCompensation
9446000
us-gaap Share Based Compensation
ShareBasedCompensation
3520000
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-463000
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
-13000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1339000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
327000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
320000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
80000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
104000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
903000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-1130000
dmtk Increase Decrease In Accounts Payable And Accrued Compensation
IncreaseDecreaseInAccountsPayableAndAccruedCompensation
1858000
dmtk Increase Decrease In Accounts Payable And Accrued Compensation
IncreaseDecreaseInAccountsPayableAndAccruedCompensation
-218000
dmtk Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
1056000
dmtk Increase Decrease In Accrued Liabilities And Deferred Revenue
IncreaseDecreaseInAccruedLiabilitiesAndDeferredRevenue
1571000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39426000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21937000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
25150000
us-gaap Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
36906000
dmtk Proceeds From Sale Of Marketable Securities
ProceedsFromSaleOfMarketableSecurities
350000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
18475000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1664000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1577000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7989000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38483000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
77000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
70271000
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
782000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
677000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
401000
dmtk Payments Of Deferred Underwriting Fees
PaymentsOfDeferredUnderwritingFees
1363000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
966000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
80000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
230252000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
59671000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
182837000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-749000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24248000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15374000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
207085000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14625000
us-gaap Interest Paid Net
InterestPaidNet
13000
dmtk Issuance Of Common Stock In Litigation Settlement
IssuanceOfCommonStockInLitigationSettlement
1011000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
462000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
76000
dmtk Reclassification Of Warrant Liability Due To Private Spac Warrants Not Held By Original Holder
ReclassificationOfWarrantLiabilityDueToPrivateSPACWarrantsNotHeldByOriginalHolder
434000
dmtk Cashless Exercise Of Common Stock Warrants
CashlessExerciseOfCommonStockWarrants
2158000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9071000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
105000
dmtk Change In Unrealized Gain Loss On Available For Sale Marketable Securities
ChangeInUnrealizedGainLossOnAvailableForSaleMarketableSecurities
-7000
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
one-for-two 
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-91552000
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
168976000
CY2020Q4 dmtk Warrant Liability Non Current
WarrantLiabilityNonCurrent
1650000
CY2020Q4 us-gaap Liabilities
Liabilities
7940000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
189868000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-128029000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
61840000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
441000
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
1228000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-2525000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1188000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-20130000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-36477000
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.87
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.15
CY2020Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-107000
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-31000
CY2020Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
116000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
50000
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
-9281000
us-gaap Net Income Loss
NetIncomeLoss
-25775000
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.49
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.61
dmtk Net Change In Net Cash Used In Operating Activities
NetChangeInNetCashUsedInOperatingActivities
0
us-gaap Depreciation
Depreciation
700000
us-gaap Depreciation
Depreciation
300000
CY2021Q3 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
8000
CY2020Q3 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
32000
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
100000
us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
32000
CY2021Q3 us-gaap Impairment Of Long Lived Assets To Be Disposed Of
ImpairmentOfLongLivedAssetsToBeDisposedOf
0
us-gaap Use Of Estimates
UseOfEstimates
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:0.04%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"> </p></td> <td style="width:4.25%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">d</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-weight:normal;"/>Use of Estimates </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.3%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires that management make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the amounts of revenues and expenses reported during the period. On an ongoing basis, management evaluates these estimates and judgments, including but not limited to those related to assay revenue, stock-based compensation, short-term marketable securities, accounts receivable, accrued bonus, warrant liability, right-of-use (“ROU”) assets and the realization of deferred tax assets. Actual results may differ from those estimates. </p>
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
24248000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
204061000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15374000
CY2020Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14625000
CY2021Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
3024000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
24248000
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
207085000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
15374000
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
14625000
CY2021Q3 us-gaap Depreciation
Depreciation
300000
CY2020Q3 us-gaap Depreciation
Depreciation
200000
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:4.25%;white-space:nowrap" valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">(</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">i</span><span style="font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">)</span></p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:18pt;font-weight:bold;font-style:italic;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;"><span style="font-weight:normal;"/>Concentration of Credit Risk </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:6pt;margin-left:4.25%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. As of September 30, 2021, the Company maintained $100.1 million in a sweep account, which maintains cash balances throughout various interest bearing bank accounts under the $250,000 insurance limit provided by the Federal Deposit Insurance Corporation for one federally insured financial institution. Approximately $85.7 million was held in excess of the Federal Deposit Insurance Corporation insured limit as of September 30, 2021. The Company has not experienced any losses in such accounts. </p>
CY2021Q3 us-gaap Deposits Money Market Deposits
DepositsMoneyMarketDeposits
100100000
CY2021Q3 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2021Q3 us-gaap Cash Uninsured Amount
CashUninsuredAmount
85700000
dmtk Number Of Revenue Streams
NumberOfRevenueStreams
2
CY2021Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3030000
CY2020Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1362000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
8673000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3764000
CY2021Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1400000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
900000
CY2021Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
0
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
600000
CY2021Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
300000
CY2021Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3700000
CY2020Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
9400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
3500000
CY2021Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
36800000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2020Q4 dmtk Computer Equipment Gross
ComputerEquipmentGross
38000
CY2021Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
124000
CY2020Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
109000
CY2021Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
1066000
CY2020Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
727000
CY2020Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
2544000
CY2021Q3 dmtk Computer Equipment Gross
ComputerEquipmentGross
171000
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
45392000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
5000
CY2021Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
13000
CY2021Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
45384000
CY2020Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
39530000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7000
CY2020Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
8000
CY2020Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
39529000
CY2021Q3 dmtk Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months
EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months
30600000
CY2021Q3 dmtk Estimated Market Value Of Remaining Debt Securities With Contractual Maturities Of Up To23 Months
EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo23Months
14800000
CY2020Q4 dmtk Estimated Market Value Of Debt Securities With Contractual Maturities Of Less Than12 Months
EstimatedMarketValueOfDebtSecuritiesWithContractualMaturitiesOfLessThan12Months
37300000
CY2020Q4 dmtk Estimated Market Value Of Remaining Debt Securities With Contractual Maturities Of Up To14 Months
EstimatedMarketValueOfRemainingDebtSecuritiesWithContractualMaturitiesOfUpTo14Months
2300000
CY2021Q3 us-gaap Prepaid Insurance
PrepaidInsurance
145000
CY2020Q4 us-gaap Prepaid Insurance
PrepaidInsurance
1172000
CY2021Q3 dmtk Prepaid Trade Shows Current
PrepaidTradeShowsCurrent
295000
CY2021Q3 dmtk Prepaid Software Fees
PrepaidSoftwareFees
676000
CY2020Q4 dmtk Prepaid Software Fees
PrepaidSoftwareFees
214000
CY2020Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
56000
CY2021Q3 dmtk Prepaid Employee Compensation
PrepaidEmployeeCompensation
275000
CY2021Q3 us-gaap Other Assets Current
OtherAssetsCurrent
178000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
79000
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1569000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1521000
CY2021Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
4216000
CY2021Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
5577000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3418000
CY2021Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1282000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
687000
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
4295000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2731000
CY2021Q3 us-gaap Accrued Vacation Current
AccruedVacationCurrent
1052000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
606000
CY2021Q3 dmtk Accrued Bonus And Deferred Compensation Current
AccruedBonusAndDeferredCompensationCurrent
2412000
CY2020Q4 dmtk Accrued Bonus And Deferred Compensation Current
AccruedBonusAndDeferredCompensationCurrent
1469000
CY2021Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3464000
CY2020Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2075000
CY2021Q3 dmtk Accrued Consulting Services Current
AccruedConsultingServicesCurrent
1160000
CY2020Q4 dmtk Accrued Consulting Services Current
AccruedConsultingServicesCurrent
285000
CY2021Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
790000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
478000
CY2021Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1950000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
763000
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q3 us-gaap Stock Issued During Period Shares Conversion Of Convertible Securities
StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
615385
CY2021Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
4237288
CY2021Q1 dmtk Stock Purchased By Underwriters Pursuant To Option Granted
StockPurchasedByUnderwritersPursuantToOptionGranted
635593
CY2021Q1 dmtk Underwriters Grant Period Option
UnderwritersGrantPeriodOption
P30D
CY2021Q1 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
4872881
CY2021Q1 dmtk Stock Purchased By Underwriters Pursuant To Option Granted
StockPurchasedByUnderwritersPursuantToOptionGranted
635593
CY2021Q1 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
29.50
CY2021Q1 dmtk Gross Proceeds From Offering Before Deducting Underwriting Discounts And Commissions And Other Offering Expenses
GrossProceedsFromOfferingBeforeDeductingUnderwritingDiscountsAndCommissionsAndOtherOfferingExpenses
143700000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
134600000
CY2021Q3 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
4647
CY2020Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
7332
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
dmtk Percentage Of Useful Lives Of Assets
PercentageOfUsefulLivesOfAssets
0.75
us-gaap Depreciation And Amortization
DepreciationAndAmortization
100000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10000000
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
388000
CY2020Q4 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
362000
CY2021Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
27000
CY2020Q4 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
27000
CY2021Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
361000
CY2020Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
335000
CY2021Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
145000
CY2020Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
109000
CY2021Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
216000
CY2020Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
226000
us-gaap Description Of Lessee Leasing Arrangements Operating Leases
DescriptionOfLesseeLeasingArrangementsOperatingLeases
In January 2013, DermTech Operations entered into a non-cancelable lease agreement for its operating facilities in Torrey Pines (the “Torrey Lease”). In January 2014, DermTech Operations signed an amendment to the Torrey Lease to extend the term through January 2017. In November 2016, DermTech Operations signed a second amendment to the Torrey Lease to extend the term through March 2022. In August 2019, DermTech Operations signed a third amendment to the Torrey Lease to add additional space, and in September 2019, the Company signed a fourth amendment to the Torrey Lease to add additional space. In February 2020, the Company signed a fifth amendment to the Torrey Lease to add additional space. In connection with the Business Combination, the Company assumed all obligations under the Torrey Lease, as amended, from DermTech Operations.
CY2021Q3 dmtk Tenant Improvement Allowance
TenantImprovementAllowance
300000
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-04-30
us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
an option to extend the lease term on all leased space for one additional three-year term
CY2021Q1 us-gaap Lessee Operating Lease Remaining Lease Term
LesseeOperatingLeaseRemainingLeaseTerm
P28M
CY2021Q1 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
4.04
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
3100000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2800000
CY2021Q1 dmtk Tenant Improvement Allowance
TenantImprovementAllowance
300000
CY2021Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
379000
us-gaap Operating Lease Cost
OperatingLeaseCost
1023000
CY2021Q3 us-gaap Variable Lease Cost
VariableLeaseCost
171000
us-gaap Variable Lease Cost
VariableLeaseCost
486000
CY2021Q3 dmtk Operating Lease Costs
OperatingLeaseCosts
550000
dmtk Operating Lease Costs
OperatingLeaseCosts
1509000
CY2021Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
17000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
53000
CY2021Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
5000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
13000
CY2021Q3 dmtk Finance Lease Cost
FinanceLeaseCost
22000
dmtk Finance Lease Cost
FinanceLeaseCost
66000
us-gaap Operating Lease Payments
OperatingLeasePayments
1516000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
13000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
80000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
9071000
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
105000
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0578
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0576
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
456000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
1848000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1147000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
688000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
709000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
5658000
CY2021Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
42000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
159000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
149000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
24000
CY2021Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
8000
CY2021Q3 dmtk Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
6000
CY2021Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
388000
CY2021Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
10506000
CY2021Q3 dmtk Operating And Capital Lease Liability Payments Remainder Of Fiscal Year
OperatingAndCapitalLeaseLiabilityPaymentsRemainderOfFiscalYear
498000
CY2021Q3 dmtk Operating And Capital Lease Liability Payments Due Next Twelve Months
OperatingAndCapitalLeaseLiabilityPaymentsDueNextTwelveMonths
2007000
CY2021Q3 dmtk Operating And Capital Lease Liability Payments Due Year Two
OperatingAndCapitalLeaseLiabilityPaymentsDueYearTwo
1296000
CY2021Q3 dmtk Operating And Capital Lease Liability Payments Due Year Three
OperatingAndCapitalLeaseLiabilityPaymentsDueYearThree
712000
CY2021Q3 dmtk Operating And Capital Lease Liability Payments Due Year Four
OperatingAndCapitalLeaseLiabilityPaymentsDueYearFour
717000
CY2021Q3 dmtk Operating And Capital Lease Liability Payments Due Thereafter
OperatingAndCapitalLeaseLiabilityPaymentsDueThereafter
5664000
CY2021Q3 dmtk Operating And Capital Lease Liability Payments Due
OperatingAndCapitalLeaseLiabilityPaymentsDue
10894000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
0

Files In Submission

Name View Source Status
0001564590-21-055781-index-headers.html Edgar Link pending
0001564590-21-055781-index.html Edgar Link pending
0001564590-21-055781.txt Edgar Link pending
0001564590-21-055781-xbrl.zip Edgar Link pending
dmtk-10q_20210930.htm Edgar Link pending
dmtk-10q_20210930_htm.xml Edgar Link completed
dmtk-20210930.xsd Edgar Link pending
dmtk-20210930_cal.xml Edgar Link unprocessable
dmtk-20210930_def.xml Edgar Link unprocessable
dmtk-20210930_lab.xml Edgar Link unprocessable
dmtk-20210930_pre.xml Edgar Link unprocessable
dmtk-ex311_6.htm Edgar Link pending
dmtk-ex312_7.htm Edgar Link pending
dmtk-ex321_8.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending